Tonix Pharmaceuticals (TNXP) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-2.75
-2.01
-1.26
-0.52

Details

Expected EPS
-2.75
Actual EPS
-2.68
Surprise EPS
0.07
Surprise Percent
+2.55%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -2.68 per share for Q2 2023.

0 Comments

Share your thoughts